California Cancer Reporting System Standards, Volume III
Eureka Edits
IF503: CS Ext, LN, Mets at DX, SSF 1, Retinoblastoma (CS)
Edit Sets:
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
Fields:
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
Behavior Code ICD-O-3 [NAACCR #523]
CS Extension [NAACCR #2810]
CS Lymph Nodes [NAACCR# 2830]
CS Mets at DX [Std# 2850]
CS Site-Specific Factor 1 [NAACCR #2880]
CS Site-Specific Factor25 [NAACCR #2879]
Message:
IF 503: Conflict among schema, CS Extension (value), CS Lymph Nodes (value) CS Mets at DX (value), CS Site-Specific Factor 1(value)
Specification:
This edit is skipped if any of the following conditions are true:
1. CS Extension, CS Lymph Nodes, CS Mets at DX, or CS Site-Specific Factor 1 is blank
2. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
3. CS schema is invalid
This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.
If schema = Retinoblastoma:
1. If CS Extension = 950 (no evidence of primary tumor), then at least one of the following fields must show that tumor is present; that is, at least one of the following must be true:
CS Site-Specific Factor 1 must = 300-810, or 999
CS Lymph Nodes must = 100-800
CS Mets at DX must = 10-80
2. If CS Site-Specific Factor 1 = 950 (no evidence of primary tumor), then at least one of the following fields must show that tumor is present; that is, at least one of the following must be true:
CS Extension must = 110-800
CS Lymph Nodes must = 100-800
CS Mets at DX must = 10-80
Historical Changes:
In the SEER*Edits software, the title of this edit is: IF349.
2011 Data Item Changes: New edit - added to NAACCR v12.1 metafile.
04/2014: Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll."